Cannabidiol (CBD) is not considered a ‘narcotic drug’ under European law.
In November 2020, the European Court of Justice published a judgement stating that cannabidiol extracted from the cannabis plant should not be considered a drug under the 1961 United Nations Single Convention on Narcotic Drugs.
Examining the legality of these measures that restricted the free movement of goods within the EU, the court also stated that CBD extracted from cannabis was not a drug within the meaning of the 1961 Convention; and that the EU industrial hemp regulations were not applicable to the CBD extract, as it is not an agricultural product within those regulations’ definitions.
This means it is now legal to import US extracts below 0.2% THC, as example remediated crude or isolates, for further manufacturing. CBD extracts do not have to be from EU hempseed genetics since CBD extracts are not falling under EU hemp regulations.